CIPO Patents = 1

EPO Patents = 2

Trademarks = 1

Forward Citations = 19

Loading Chart...

4 inventors (with patents filed for the assignee):

Lance Gavin Laing (9 out of 27 patents)

Brian Francis Sullivan (7 out of 7 patents)

Ben Rich (2 out of 2 patents)

4. Abhijit Dandapat (2 out of 2 patents)

9 patents: Sort by Forward Citations

1. 12350276 - Methods for the treatment of cancer using 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea (2025-07-08),

2. 12320799 - Methods of measuring signaling pathway activity for selection of therapeutic agents (2025-06-03),

3. 12215356 - Methods of preparing a primary cell sample (2025-02-04),

4. 11591573 - Methods of preparing a primary cell sample (2023-02-28),

5. 11333659 - Methods of measuring signaling pathway activity for selection of therapeutic agents (2022-05-17),

6. 11073509 - Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent (2021-07-27),

7. 10976307 - Whole cell assays and methods (2021-04-13),

8. 10041934 - Whole cell assays and methods (2018-08-07),

9. 9404915 - Whole cell assays and methods (2016-08-02),

Celcuity Inc. is a cellular analysis company that is revolutionizing personalized medicine by discovering new cancer subtypes and commercializing diagnostic tests that target them. The company's unique approach uses a proprietary platform to analyze living cells from patients and identify key cancer signaling pathways, leading to more effective treatments for patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

9 Patents

#182 in Minneapolis, MN

#929 in Minnesota

#31,665 in US

Minneapolis, MN, United States of America

Celcuity Inc.

Forward Citations = 19

4 inventors:

Lance Gavin Laing (9 out of 27 patents)

Brian Francis Sullivan (7 out of 7 patents)

Ben Rich (2 out of 2 patents)

4. Abhijit Dandapat (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com